The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key territories has introduced substantial risk . Investors are now assessing the impact of rival medications ,